IN2014DN08537A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN08537A IN2014DN08537A IN8537DEN2014A IN2014DN08537A IN 2014DN08537 A IN2014DN08537 A IN 2014DN08537A IN 8537DEN2014 A IN8537DEN2014 A IN 8537DEN2014A IN 2014DN08537 A IN2014DN08537 A IN 2014DN08537A
- Authority
- IN
- India
- Prior art keywords
- pneumonia
- heart failure
- monitoring
- treatment
- categorizing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/63—Motilins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261613311P | 2012-03-20 | 2012-03-20 | |
| PCT/NZ2013/000043 WO2013141716A1 (en) | 2012-03-20 | 2013-03-15 | Biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN08537A true IN2014DN08537A (enrdf_load_stackoverflow) | 2015-05-15 |
Family
ID=49223053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8537DEN2014 IN2014DN08537A (enrdf_load_stackoverflow) | 2012-03-20 | 2013-03-15 |
Country Status (7)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104107419A (zh) * | 2014-05-29 | 2014-10-22 | 四川大学华西医院 | 胃饥饿素在预防或/和治疗放射性肺损伤中的用途 |
| RU2020129391A (ru) * | 2018-03-02 | 2022-03-09 | Эвоник Оперейшенс ГмбХ | Способ in vitro выявления недостаточности кишечного барьера у животных |
| US12400762B2 (en) | 2018-12-11 | 2025-08-26 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy |
| US12322100B2 (en) | 2018-12-11 | 2025-06-03 | Eko.Ai Pte. Ltd. | Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity |
| US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
| US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
| US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
| CN109825567B (zh) * | 2018-12-27 | 2022-06-10 | 博奥生物集团有限公司 | 肺炎诊断用circRNA生物标志物及应用、引物和试剂 |
| CN111951215A (zh) * | 2020-06-30 | 2020-11-17 | 数坤（北京）网络科技有限公司 | 一种图像检测方法、装置及计算机可读存储介质 |
| WO2025040754A1 (en) * | 2023-08-22 | 2025-02-27 | Roche Diagnostics Gmbh | Monitoring of cardiovascular markers in interstitial fluid and its application in assessment of heart failure |
| CN117393154B (zh) * | 2023-12-12 | 2024-03-01 | 中国中医科学院医学实验中心 | 基于血清全通路氧化脂质组学筛选心力衰竭生物标志物的方法及应用 |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196265A (en) | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5310687A (en) | 1984-10-31 | 1994-05-10 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| GB8800077D0 (en) | 1988-01-05 | 1988-02-10 | Ciba Geigy Ag | Novel chimeric antibodies |
| US5843708A (en) | 1988-01-05 | 1998-12-01 | Ciba-Geigy Corporation | Chimeric antibodies |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| WO1991017440A1 (en) | 1990-05-07 | 1991-11-14 | Immunomedics, Inc. | Improved method for radiolabeling monovalent antibody fragments |
| FI922164A0 (fi) | 1990-09-14 | 1992-05-13 | Biosite Diagnostics Inc | Antikroppar mot komplex av ligandreceptorer och ligander och anvaendningen daerav vid bestaemning av ligandreceptorer. |
| CA2405246A1 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with alterred binding properties |
| US5221685A (en) | 1991-02-01 | 1993-06-22 | Ube Industries, Ltd. | Thiazoline derivative, process for preparing the same and chemical for controlling noxious organisms containing the same |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| ATE177841T1 (de) | 1991-04-10 | 1999-04-15 | Biosite Diagnostics Inc | ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung |
| JP3290988B2 (ja) | 1991-04-11 | 2002-06-10 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | 多重リガンドを同時検出する新規接合体及び検定法 |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| JP3639594B2 (ja) | 1993-05-28 | 2005-04-20 | ベイラー カレッジ オブ メディシン | 分析対象物の脱着およびイオン化のための方法および装置 |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| SG72684A1 (en) | 1993-11-12 | 2000-05-23 | Unipath Ltd | Reading devices and assay devices for use therewith |
| ES2145034T3 (es) | 1993-11-12 | 2000-07-01 | Unilever Nv | Dispositivos analiticos y procedimientos para el uso de los mismos. |
| US5647124A (en) | 1994-04-25 | 1997-07-15 | Texas Instruments Incorporated | Method of attachment of a semiconductor slotted lead to a substrate |
| GB9419267D0 (en) | 1994-09-23 | 1994-11-09 | Unilever Plc | Assay devices |
| US5792294A (en) | 1995-11-16 | 1998-08-11 | Otis Elevator Company | Method of replacing sheave liner |
| US5719600A (en) | 1995-12-12 | 1998-02-17 | Hewlett-Packard Company | Gradient calculation system and method |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| NZ516848A (en) | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
| GB9717926D0 (en) | 1997-08-22 | 1997-10-29 | Micromass Ltd | Methods and apparatus for tandem mass spectrometry |
| WO1999038194A1 (en) | 1998-01-23 | 1999-07-29 | Analytica Of Branford, Inc. | Mass spectrometry from surfaces |
| US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| US6831060B2 (en) | 1999-05-07 | 2004-12-14 | Genentech, Inc. | Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same |
| US6784154B2 (en) | 2001-11-01 | 2004-08-31 | University Of Utah Research Foundation | Method of use of erythropoietin to treat ischemic acute renal failure |
| WO2003054543A2 (en) | 2001-12-21 | 2003-07-03 | Sense Proteomic Limited | Probe for mass spectrometry |
| AUPS169202A0 (en) | 2002-04-11 | 2002-05-16 | Goetze, Jens Peter | Neuropeptide assay |
| US6780645B2 (en) | 2002-08-21 | 2004-08-24 | Lifescan, Inc. | Diagnostic kit with a memory storing test strip calibration codes and related methods |
| US7045366B2 (en) | 2003-09-12 | 2006-05-16 | Ciphergen Biosystems, Inc. | Photocrosslinked hydrogel blend surface coatings |
| US20040091961A1 (en) | 2002-11-08 | 2004-05-13 | Evans Glen A. | Enhanced variants of erythropoietin and methods of use |
| JP2006527190A (ja) | 2003-04-17 | 2006-11-30 | サイファージェン バイオシステムズ インコーポレイテッド | ナトリウム利尿ペプチドに関連したポリペプチド、並びにこれらの同定および使用法 |
| ZA200510282B (en) | 2003-07-02 | 2007-03-28 | Genentech Inc | Compositions and methods for the diagnosis and treatment of tumor |
| WO2005052593A1 (en) | 2003-10-29 | 2005-06-09 | The University Of Leicester | Detection |
| US7423139B2 (en) | 2004-01-20 | 2008-09-09 | Insight Biopharmaceuticals Ltd. | High level expression of recombinant human erythropoietin having a modified 5′-UTR |
| CA2574665C (en) | 2004-07-23 | 2014-07-15 | The Walter And Eliza Hall Institute Of Medical Research | Therapeutic and diagnostic agents |
| ES2344793T3 (es) | 2004-08-05 | 2010-09-07 | Genentech, Inc. | Antagonistas anti-cmet humanizados. |
| JP2006292623A (ja) | 2005-04-13 | 2006-10-26 | Univ Of Dundee | 心不全における突然死のマーカー |
| EP1731910A1 (en) | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases |
| NZ576061A (en) | 2006-09-07 | 2013-02-22 | Otago Innovation Ltd | Biomarkers |
| GB0712670D0 (en) | 2007-06-29 | 2007-08-08 | King S College London | Isolated peptides and uses thereof |
| JP2011516038A (ja) * | 2008-03-12 | 2011-05-26 | オタゴ イノベーション リミテッド | バイオマーカー |
| CA2776978A1 (en) * | 2009-10-21 | 2011-04-28 | Pronota N.V. | Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof |
-
2013
- 2013-03-15 ES ES13764431.6T patent/ES2661516T3/es active Active
- 2013-03-15 CN CN201380026197.XA patent/CN104470942B/zh not_active Expired - Fee Related
- 2013-03-15 EP EP13764431.6A patent/EP2828282B1/en not_active Not-in-force
- 2013-03-15 US US13/844,449 patent/US10114028B2/en not_active Expired - Fee Related
- 2013-03-15 WO PCT/NZ2013/000043 patent/WO2013141716A1/en active Application Filing
- 2013-03-15 IN IN8537DEN2014 patent/IN2014DN08537A/en unknown
- 2013-03-15 DK DK13764431.6T patent/DK2828282T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| US10114028B2 (en) | 2018-10-30 |
| US20130296240A1 (en) | 2013-11-07 |
| CN104470942B (zh) | 2018-12-14 |
| EP2828282B1 (en) | 2017-12-27 |
| DK2828282T3 (en) | 2018-03-05 |
| WO2013141716A1 (en) | 2013-09-26 |
| EP2828282A4 (en) | 2015-08-26 |
| ES2661516T3 (es) | 2018-04-02 |
| CN104470942A (zh) | 2015-03-25 |
| EP2828282A1 (en) | 2015-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN08537A (enrdf_load_stackoverflow) | ||
| EA201071324A1 (ru) | Система и способы измерения профилей биомаркеров | |
| GB2488700B (en) | Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual | |
| BR112014031365A2 (pt) | métodos de detectar doenças ou condições | |
| MX390772B (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
| WO2014201516A3 (en) | Biomarker identification | |
| MX367046B (es) | Marcadores especificos de via para diagnosticar sindrome del intestino irritable. | |
| BR112015023120A2 (pt) | método para identificar um indivíduo com uma doença ou disfunção, método para prever a responsividade de um indivíduo com uma doença ou disfunção, método para determinar a probabilidade de que um indivíduo com uma doença ou disfunção exibirá benefício do tratamento, método para selecionar uma terapia, usos de um antagonista de ligação do eixo pd-l1, ensaio para identificar um indivíduo com uma doença, kit de diagnóstico, método para avaliar uma resposta ao tratamento e método para monitorar a resposta de um indivíduo tratado | |
| WO2014028884A3 (en) | Cancer diagnostics using biomarkers | |
| EP2566983A4 (en) | SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE | |
| IN2014CN04326A (enrdf_load_stackoverflow) | ||
| GB201021399D0 (en) | Oligonucleotide probe set and methods of microbiota profiling | |
| WO2011047033A3 (en) | Biomarker for identification of melanoma tumor cells | |
| EP3751283A3 (en) | Blood-based screen for detecting neurological diseases in primary care settings | |
| WO2015094995A3 (en) | Gene signature biomarkers of tumor response to pd-1 antagonists | |
| EA201290711A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| BR112012012513A2 (pt) | método para diagnosticar síndrome do intestino irritável em um paciente, método para monitorar a progressão ou regressão da síndrome do intestino irritável em um paciente, e para designar uma terapia contra síndrome do intestino irritável a um paciente em necessidade do mesmo | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| HK1259001A1 (zh) | 癌症的预後和诊断方法 | |
| WO2013159872A8 (en) | Biomarkers for the diagnosis, prognosis, assessment and therapy stratification of syncope | |
| MX2017003370A (es) | Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica. | |
| EA201500080A1 (ru) | Способ in vitro диагностирования и мониторинга рака | |
| IN2014DN08398A (enrdf_load_stackoverflow) | ||
| EA201790696A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности | |
| NZ729773A (en) | Biomarkers for disease progression in melanoma |